SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

BTIG Research Initiates Coverage On Pacira BioSciences with Buy Rating, Announces $56 Price Target

BTIG Research initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Buy rating and a $56 price target.

Benzinga · -

BTIG Research initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Buy rating and a $56 price target.